The overall mission of the GRAND program is to advance the pharmacological treatment of tobacco and nicotine dependence.
Examples could include:
- Observational or interventional studies of pharmacotherapy
- Optimisation of the use of currently available medication
- Effectiveness of treatment in real-life settings
- Development or use of new medications for cessation or harm reduction
- Specifically designed interventions in subtypes of tobacco/nicotine users
- Use of existing databases to inform the clinical use of pharmacotherapy
- Policy interventions to increase use of pharmacotherapy
Awards are funded at up to US $200,000 (approx. AUD $255,600) per project.
GRAND is open to all investigators from around the world holding an MD, a PhD, or equivalent.
Out-of-scope topics will not be funded, including:
- Epidemiology of tobacco use
- Tobacco control policy not focused on pharmacotherapy
Applications must be submitted to the Research Branch for internal review by 24 June 2015.
Submitted applications must be accompanied by a signed and completed copy of the University’s Grant Application Cover Sheet. Submissions may be emailed to the Research Branch unless otherwise specified.
Grants Officer: Dr Don McMaster